BioCentury
ARTICLE | Finance

Fundamentally driven

Biotech winners, losers in 1Q18

April 6, 2018 11:09 PM UTC

Continued struggles by the mega-cap bellwethers and the resurgence of volatility in global equity markets were the major themes of 1Q18, whipsawing biotech stocks throughout the quarter but leaving index values little changed on the whole.

Deeper inspection revealed a sectorwide dispersion in market prices, however, with fundamental drivers of value ultimately determining the quarter’s biggest winners and losers...